JP2013504075A5 - - Google Patents

Download PDF

Info

Publication number
JP2013504075A5
JP2013504075A5 JP2012528396A JP2012528396A JP2013504075A5 JP 2013504075 A5 JP2013504075 A5 JP 2013504075A5 JP 2012528396 A JP2012528396 A JP 2012528396A JP 2012528396 A JP2012528396 A JP 2012528396A JP 2013504075 A5 JP2013504075 A5 JP 2013504075A5
Authority
JP
Japan
Prior art keywords
protein
fgf
multiple sclerosis
anosmin
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012528396A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013504075A (ja
Filing date
Publication date
Priority claimed from ES200930661A external-priority patent/ES2356540B1/es
Priority claimed from ES201030090A external-priority patent/ES2369099B1/es
Application filed filed Critical
Priority claimed from PCT/ES2010/070584 external-priority patent/WO2011045456A2/es
Publication of JP2013504075A publication Critical patent/JP2013504075A/ja
Publication of JP2013504075A5 publication Critical patent/JP2013504075A5/ja
Pending legal-status Critical Current

Links

JP2012528396A 2009-09-07 2010-09-07 疾患組織病理の新規バイオマーカー Pending JP2013504075A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ESP200930661 2009-09-07
ES200930661A ES2356540B1 (es) 2009-09-07 2009-09-07 Método para predecir las características histopatológicas de las lesiones de un sujeto con una enfermedad desmielinizante del sistema nervioso central.
ES201030090A ES2369099B1 (es) 2010-01-25 2010-01-25 La proteina Anosmina-1 como biomarcador para la clasificación histopatológica de lesiones de un sujeto con enfermedad desmielinizante del Sistema Nervioso Central.
ESP201030090 2010-01-25
PCT/ES2010/070584 WO2011045456A2 (es) 2009-09-07 2010-09-07 Nuevos biomarcadores de la histopatología de enfermedades desmielinizantes

Publications (2)

Publication Number Publication Date
JP2013504075A JP2013504075A (ja) 2013-02-04
JP2013504075A5 true JP2013504075A5 (https=) 2013-10-24

Family

ID=43334531

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012528396A Pending JP2013504075A (ja) 2009-09-07 2010-09-07 疾患組織病理の新規バイオマーカー

Country Status (6)

Country Link
US (1) US20120252688A1 (https=)
EP (1) EP2477030A2 (https=)
JP (1) JP2013504075A (https=)
AU (1) AU2010306515A1 (https=)
CA (1) CA2773527A1 (https=)
WO (1) WO2011045456A2 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2762602B1 (fr) * 1997-04-28 1999-06-04 Inst Nat Sante Rech Med Moyens pour la detection precoce de pathologies auto-immunes inflammatoires

Similar Documents

Publication Publication Date Title
Fan et al. Diagnosing sepsis–The role of laboratory medicine
JP5270684B2 (ja) 脂肪肝疾患用のバイオマーカー及びその使用方法
Qiao et al. Serum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection
Baranyi et al. Nitric oxide-related biological pathways in patients with major depression
Singh et al. Non-invasive biomarkers for celiac disease
CA3052349C (en) Proadm as marker indicating an adverse event
CN103403549B (zh) 败血症的预后的预测方法
Berezin et al. Pattern of circulating microparticles in chronic heart failure patients with metabolic syndrome: Relevance to neurohumoral and inflammatory activation
KR20160029869A (ko) 질병의 발달을 모니터링하고 치료의 효율을 평가하기 위한 새로운 바이오마커
WO2018029214A1 (en) Histones and/or proadm as markers indicating an adverse event
RU2764766C2 (ru) Гистоны и/или proadm в качестве маркеров, свидетельствующих об органной дисфункции
JP2014525593A (ja) 心臓血管リスクを予測するための診断分析
Ren et al. Recent advances in biomarkers for Parkinson’s disease focusing on biochemicals, omics and neuroimaging
JP2008509411A (ja) 肝線維症の診断方法
Singh et al. Elevated serum SIRT 2 may differentiate Parkinson’s disease from atypical parkinsonian syndromes
RU2013158667A (ru) Способ диагностики болезни гоше
WO2014018643A1 (en) Oxidative biomarkers in predicting risk of stroke, transient ischemic attack (tia) and peripheral arterial disease (pad)
Kazamia et al. Tissue and plasma proteomic profiling indicates AHSG as a potential biomarker for ascending thoracic aortic aneurysms
JP2016511407A5 (https=)
JP2008538812A5 (https=)
Pendyala et al. Quantitative plasma proteomic profiling identifies the vitamin E binding protein afamin as a potential pathogenic factor in SIV induced CNS disease
US10557860B2 (en) Circulating pulmonary hypertension biomarker
Dumitrache et al. Evaluating the Discriminative Performance of Noninvasive Biomarkers in Chronic Hepatitis B/C, Alcoholic Cirrhosis, and Nonalcoholic Cirrhosis: A Comparative Analysis
CN110988351B (zh) 血管细胞黏附分子在制备抑郁症诊断治疗相关产品的用途
JP2013504075A5 (https=)